Articles From: CTG Reports 2014 Third Quarter Results to CU Inc. Eligible Dividends


- JAMES BOLDT, CTG CEO PASSED AWAY UNEXPECTEDLY ON OCTOBER 13, 2014 - HEADCOUNT INCREASED BY 100 - HEALTHCARE REVENUE WAS 27% OF REVENUE - TOTAL SOLUTIONS REVENUE WAS 36% OF REVENUE - STRONG BALANCE SHEET WITH NO DEBT AND A $28.3 MILLION CASH POSITION BUFFALO, N.Y. , Oct.
Sign-up for CTG Reports 2014 Third Quarter Results investment picks
BUFFALO, N.Y. , Sept.
Sign-up for CTG to Present at the 2014 Western New York Investors Conference investment picks
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - - Acquisition Eliminates Potential $209 Million in Future Developmental and Sales Milestone Payments by CTI Under Prior Agreement with Chroma - SEATTLE , Oct.
Sign-up for CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy investment picks
2014/9/17
- Total Deal Valued at up to Approximately $133.5 Million; Approximately $18.1 million Upfront - - CTI Retains 100% Commercialization Rights to PIXUVRI in U.S. and Certain E.U. Territories - - Conference Call Scheduled for Today at 8:30 a.m. EDT - SEATTLE , Sept.
Sign-up for CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® investment picks
-Profile Supports Potential Role in Modulating Tumor Microenvironment in Blood-Related Cancers, Including AML, MDS, CMML and CLL- -Analysis Also Provides Scientific Basis for Pacritinib's Lack of Myelosuppression, a Unique Attribute Among Agents in Development for Myelofibrosis- SEATTLE , Dec.
Sign-up for CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers investment picks
-Significant synergy resulted with combination treatment of pacritinib and cytarabine or a MEK inhibitor- SEATTLE , Dec.
Sign-up for CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells investment picks
2014/11/6
SEATTLE , Nov.
Sign-up for CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock investment picks
2014/11/7
SEATTLE , Nov.
Sign-up for CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock investment picks
SEATTLE , Dec.
Sign-up for CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX® investment picks
2014/10/29
- Entered into Potential $133.5 Million Agreement with SERVIER for PIXUVRI in U.S. and Certain E.U. Territories - - Acquired Worldwide Rights to Tosedostat, a Late-Stage Oral Targeted Therapy for Patients with AML and MDS; Retired Potential $209 Million in Development and Sales Milestones to Chroma - - Conference Call Scheduled for Today at 4:30 p.m. Eastern Time - SEATTLE , Oct.
Sign-up for CTI BioPharma Reports Third Quarter 2014 Financial Results investment picks
SEATTLE , Nov.
Sign-up for CTI BioPharma to Present at the Upcoming Investor Conferences investment picks
http://media.marketwire.com/attachments/201308/178124_cti-1half.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155279&ProfileId=051205&sourceType=1 LAKE BARRINGTON, IL --
Sign-up for CTI Industries Corporation Adopts "Made in USA" Program investment picks
http://media.marketwire.com/attachments/201308/178124_cti-1half.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158516&ProfileId=051205&sourceType=1 LAKE BARRINGTON, IL --
Sign-up for CTI Industries Corporation Reports Return to Profit in Third Quarter and for Nine Months investment picks
SHANGHAI , Nov.
Sign-up for Ctrip Reports Unaudited Third Quarter 2014 Financial Results investment picks
SHANGHAI , Sept.
Sign-up for Ctrip To Purchase Certain Premises In Sky SOHO investment picks
CTS Corporation (NYSE: CTS) today announced third quarter 2014 results: Revenues were $100.0 million, down 3.6% compared to revenues from continuing operations in third quarter of 2013.
Sign-up for CTS Announces Third Quarter 2014 Results investment picks
CTS Corporation (NYSE: CTS) will release earnings for the third quarter 2014 at approximately 4:30 p.m. (EDT) on Monday, October 27, 2014.
Sign-up for CTS Corporation Announces Dates for Third Quarter 2014 Earnings Release and Conference Call investment picks
The Board of Directors of CTS Corporation (NYSE: CTS) announced the fourth quarter dividend of $0.04 per share, payable January 30, 2015, to shareholders of record at the close of business on December 26, 2014.
Sign-up for CTS Corporation Declares Quarterly Dividend investment picks
2014/9/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0968785001&sourceType=1 http://www.ccnmatthews.com/logos/20070727-tel0727.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for CTV Now Available on Demand and on the go on TELUS Optik TV investment picks
2014/12/3
By Joann S.
Sign-up for CtW Urges Vote Against Walgreen's $14.7 Billion Deal For Alliance Boots investment picks
2014/10/8
http://media.marketwire.com/attachments/201410/TN-282023_.jpg Apple Retail Store in China http://media.marketwire.com/attachments/201004/5648_CTXlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1150200&ProfileId=051205&sourceType=1 BOCA RATON, FL --
Sign-up for CTX Virtual Technologies, Inc. Receives First Order From China Apple Retail Stores for the VK200 Virtual Keyboard Units investment picks
CU Bancorp (Nasdaq: CUNB), the parent bank holding company of California United Bank, announced today that its 2014 Annual Meeting of Shareholders will be held on Friday, November 14, 2014 at 9:00 a.m. Pacific Time, at the Warner Center Marriott Hotel, 21850 Oxnard Street, Woodland Hills, California 91367.
Sign-up for CU Bancorp Announces 2014 Annual Shareholders Meeting Date and Record Date investment picks
CU Bancorp (NASDAQ: CUNB ) today announced that on November 30, 2014, it completed its previously announced acquisition of 1 st Enterprise Bank (OTCQB:FENB) through the merger of 1 st Enterprise Bank with and into California United Bank, the wholly-owned subsidiary of CU Bancorp.
Sign-up for CU Bancorp Announces the Completion of the Merger of 1st Enterprise Bank into California United Bank investment picks
CU Bancorp (NASDAQ: CUNB), the parent company of wholly owned California United Bank, today reported net income of $2.55 million, or $0.23 per fully diluted share, for the third quarter of 2014, an increase of 2.9% from net income of $2.48 million, or $0.23 per fully diluted share, for the third quarter of 2013.
Sign-up for CU Bancorp Reports Net Income of $2.55 Million and Record Core Net Income of $3.18 Million for Third Quarter of 2014 investment picks
CU Bancorp (NASDAQ: CUNB) and 1 st Enterprise Bank (OTCQB: FENB) today announced that they have received all bank regulatory approvals necessary to authorize the merger of 1 st Enterprise Bank with California United Bank.
Sign-up for CU Bancorp, California United Bank and 1st Enterprise Bank Announce Receipt of Regulatory Approvals for Merger investment picks
2014/10/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0972135001&sourceType=1 http://www.ccnmatthews.com/logos/20060404-main_atco-cdnutil.jpg http://www.ccnmatthews.com/logos/20060404-jts_atco-cu.jpg CALGARY, ALBERTA --
Sign-up for CU Inc. Announces Debenture Issue investment picks
2014/10/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0973632001&sourceType=1 http://www.ccnmatthews.com/logos/20060404-main_atco-cdnutil.jpg http://www.ccnmatthews.com/logos/20060404-jts_atco-cu.jpg CALGARY, ALBERTA --
Sign-up for CU Inc. Eligible Dividends investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: CTG Reports 2014 Third Quarter Results to CU Inc. Eligible Dividends
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent